- IMPACT DUCHENNE: Company aligned with FDA on Phase 3 randomized, double-blind, placebo-controlled trial design -- IMPACT DUCHENNE: Company anticipates first participant dosing in Q1 2026 - - Company plans for additional meetings with the FDA in 1H 2026 to align on a potential accelerated approval pathway for SGT-003 - - INSPIRE DUCHENNE: SGT-003 continues to be generally well tolerated with 36 participants dosed as of February 9, 2026, in Phase 1/2 trial - CHARLESTOWN, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE ...

About Sabre Corporation Sabre Corporation is a leading technology company that takes on the biggest opportunities and solves the most complex challenges in travel. Sabre harnesses speed, scale and insights to build tomorrow's technology today – empowering airlines, hoteliers, agencies and other partners to retail, distribute and fulfill travel worldwide. Headquartered in Southlake, Texas, USA, with employees across the world, Sabre serves customers in more than 160 countries globally. For more information v ...

Reconciled On-Chain Data Confirms $2,464,116 in Actual Received Income for January; Annualized Run Rate Approaches $30 Million SCOTTSDALE, ARIZONA / ACCESS Newswire / February 9, 2026 / Bonk, Inc. (Nasdaq:BNKK) today released confirmed performance data for the full month of January 2026. Following a breakout fourth quarter, the Company's primary revenue-generating asset, BONK.fun, has delivered a continued trajectory of significant growth to start the new fiscal year. ...

My approach as a dividend-focused investor and analyst is to focus on companies with reliable and proven business models. That's because it would be pointless for one to save, invest, and grind their wayScott Kaufman, aka Treading Softly, learned about investing firsthand from over a decade of financial sector experience. He is the lead analyst for Dividend Kings providing actionable insight into high quality dividend growing and undervalued opportunities. His focus is to see a bountiful harvest of cash div ...

The S&P 500 Index and its top ETFs like VOO and SPY staged a strong comeback on Friday as investors bought the dip in technology stocks after big companies revealed their AI spending details. ...

LAVAL, Québec, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Savaria Corporation (“Savaria”) (TSX:SIS), a global leader in the accessibility industry, is pleased to announce that it has completed the acquisition of substantially all the assets of Baxter Residential Elevators, LLC (“BRE”), a leading dealer and installer of home elevators and lifts based in Frisco, Texas. Founded in 2004, BRE has been a long-time Savaria dealer serving the Dallas-Fort Worth Metroplex and generated approximately US$4 million (C$5.5 millio ...

TAMPA, Fla., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI) (“Upexi” or the “Company”), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that management will participate in one-on-one investor meetings at A.G.P.’s Digital Asset Innovation Summit on February 22-25, 2026, at the Park Hyatt in Beaver Creek, Colorado. A.G.P.’s Digital Asset Innovation SummitDate: February 22-25, 2026Location: Park Hyatt, Beaver Creek, ColoradoAttendees: Brian Rudic ...

Exploring the combination with atezolizumab and radiation therapyStudy led by Yale University MADRID, Spain and CAMBRIDGE, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, announced today that the first patient has been dosed in an investigator-initiated Phase Ib dose-finding trial evaluating iadademstat, Oryzon’s potent and selective LSD1 inhibitor, in combination with radiotherapy a ...

TORONTO, ONTARIO / ACCESS Newswire / February 9, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce that its wholly owned subsidiary, Paymetrex Payment Solutions Inc. ("Paymetrex"), has formally launched a comprehensive patent licensing program designed to monetize its extensive intellectual property portfolio in the payments and transaction processing space. As part of this initiative, Paymetrex has entered into a non-exclusive patent license ...

FAIRFIELD, NEW JERSEY / ACCESS Newswire / February 9, 2026 / Jerash Holdings (US), Inc. (NASDAQ:JRSH) (the "Company" or "Jerash"), which manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands, today announced significantly improved financial results for its fiscal 2026 third quarter ended December 31, 2025. Fiscal 2026 Third Quarter Highlights Revenue increased 18.0 percent to $41.8 million, from $35.4 million in the prior year quarter. ...